Kiniksa Pharmaceuticals International (KNSA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $79.94, +1.40% vs the prior close of $78.84.
- Volume 1.48M shares, 3.0x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KNSA rises 1.4% to $79.94, a 1-month high on 3.0x normal volume. Closed at $79.94, +1.40% vs the prior close of $78.84. Day range $79.62–$82.98, opened at $79.85.
KNSA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — KNSA rises 1.4% to $79.94, a 1-month high on 3.0x normal volume
- Closed at $79.94, +1.40% vs the prior close of $78.84. Day range $79.62–$82.98, opened at $79.85.
- Volume was 1.48M shares, 3.0x its 50-day average of 494.03K — unusually heavy trading.
- Price is +2.8% vs its 50-day average ($77.79) and +38.2% vs its 200-day average ($57.85).
- 52-week range $35.20–$82.98; today's close sits at 94% of that range, 3.7% below the 52-week high.
Oct 14, 2026 — KNSA rises 0.4% to $78.84
- Closed at $78.84, +0.39% vs the prior close of $78.53. Day range $77.70–$79.96, opened at $78.11.
- Volume was 576.50K shares, 1.2x its 50-day average of 495.74K.
- Price is +1.4% vs its 50-day average ($77.76) and +36.7% vs its 200-day average ($57.65).
- 52-week range $35.20–$82.94; today's close sits at 91% of that range, 4.9% below the 52-week high.
Oct 13, 2026 — KNSA dips 0.9% to $78.53
- Closed at $78.53, -0.90% vs the prior close of $79.24. Day range $78.45–$80.00, opened at $79.21.
- Volume was 575.80K shares, 1.2x its 50-day average of 499.93K.
- Price is +1.1% vs its 50-day average ($77.70) and +36.6% vs its 200-day average ($57.47).
- 52-week range $35.20–$82.94; today's close sits at 91% of that range, 5.3% below the 52-week high.
Oct 12, 2026 — KNSA dips 0.7% to $79.24
- Closed at $79.24, -0.68% vs the prior close of $79.78. Day range $78.82–$80.99, opened at $80.00.
- Volume was 340.90K shares, 0.7x its 50-day average of 513.80K.
- Price is +2.1% vs its 50-day average ($77.60) and +38.3% vs its 200-day average ($57.29).
- 52-week range $35.20–$82.94; today's close sits at 92% of that range, 4.5% below the 52-week high.
Oct 9, 2026 — KNSA rises 1.3% to $79.78, a 1-month high, 7 up days in a row
- Closed at $79.78, +1.31% vs the prior close of $78.75. Day range $78.03–$80.50, opened at $78.24.
- Volume was 430.30K shares, 0.8x its 50-day average of 524.13K.
- Price is +2.9% vs its 50-day average ($77.50) and +39.7% vs its 200-day average ($57.10).
- 52-week range $35.20–$82.94; today's close sits at 93% of that range, 3.8% below the 52-week high.
- That makes 7 straight gains.
Oct 8, 2026 — KNSA rises 1.0% to $78.75, 6 up days in a row
- Closed at $78.75, +1.01% vs the prior close of $77.96. Day range $75.44–$78.83, opened at $77.18.
- Volume was 411.60K shares, 0.8x its 50-day average of 543.50K.
- Price is +1.7% vs its 50-day average ($77.47) and +38.3% vs its 200-day average ($56.92).
- 52-week range $35.20–$82.94; today's close sits at 91% of that range, 5.1% below the 52-week high.
- That makes 6 straight gains.
Oct 7, 2026 — KNSA rises 1.1% to $77.96, 5 up days in a row
- Closed at $77.96, +1.13% vs the prior close of $77.09. Day range $74.70–$79.22, opened at $76.18.
- Volume was 380.40K shares, 0.6x its 50-day average of 593.38K.
- Price is +0.6% vs its 50-day average ($77.51) and +37.4% vs its 200-day average ($56.75).
- 52-week range $35.20–$82.94; today's close sits at 90% of that range, 6.0% below the 52-week high.
- That makes 5 straight gains.
Oct 6, 2026 — KNSA rises 1.0% to $77.09, 4 up days in a row
- Closed at $77.09, +1.02% vs the prior close of $76.31. Day range $73.84–$77.32, opened at $76.00.
- Volume was 378.70K shares, 0.6x its 50-day average of 602.49K.
- Price is -0.6% vs its 50-day average ($77.54) and +36.3% vs its 200-day average ($56.57).
- 52-week range $35.20–$82.94; today's close sits at 88% of that range, 7.1% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — KNSA rises 0.7% to $76.31, 3 up days in a row
- Closed at $76.31, +0.69% vs the prior close of $75.79. Day range $75.29–$76.79, opened at $75.97.
- Volume was 391.50K shares, 0.6x its 50-day average of 607.06K.
- Price is -1.2% vs its 50-day average ($77.27) and +35.3% vs its 200-day average ($56.39).
- 52-week range $35.20–$82.94; today's close sits at 86% of that range, 8.0% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — KNSA rises 0.8% to $75.79
- Closed at $75.79, +0.76% vs the prior close of $75.22. Day range $74.56–$76.22, opened at $75.58.
- Volume was 376.30K shares, 0.6x its 50-day average of 605.97K.
- Price is -1.6% vs its 50-day average ($77.00) and +34.8% vs its 200-day average ($56.21).
- 52-week range $35.20–$82.94; today's close sits at 85% of that range, 8.6% below the 52-week high.
KNSA latest news & SEC filings
Every SEC filing by or about KNSA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Megna Michael R sold 4,600 shares at $80.30 (≈$369.38K) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 29, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Jul 28, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade KNSA
- Last results release: Jul 28, 2026 (8-K Item 2.02). Previous ones: Apr 28, 2026, Feb 24, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Oct 27, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.06% (largest 2.6%).
- Liquidity: about 574.78K shares (≈$45.95M) trade per day on average.
- 52-week position: $79.94 vs a range of $35.20–$82.98 (94% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Michael R Megna sold 4,600 shares on Sep 3, 2026.
- Latest filings: 10-Q Jul 28, 2026; 8-K Jul 28, 2026; 8-K May 29, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KNSA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 79.85 | 82.98 | 79.62 | 79.94 | 1.48M |
| Oct 14, 2026 | 78.11 | 79.96 | 77.70 | 78.84 | 576.50K |
| Oct 13, 2026 | 79.21 | 80.00 | 78.45 | 78.53 | 575.80K |
| Oct 12, 2026 | 80.00 | 80.99 | 78.82 | 79.24 | 340.90K |
| Oct 9, 2026 | 78.24 | 80.50 | 78.03 | 79.78 | 430.30K |
| Oct 8, 2026 | 77.18 | 78.83 | 75.44 | 78.75 | 411.60K |
| Oct 7, 2026 | 76.18 | 79.22 | 74.70 | 77.96 | 380.40K |
| Oct 6, 2026 | 76.00 | 77.32 | 73.84 | 77.09 | 378.70K |
| Oct 5, 2026 | 75.97 | 76.79 | 75.29 | 76.31 | 391.50K |
| Oct 2, 2026 | 75.58 | 76.22 | 74.56 | 75.79 | 376.30K |
| Oct 1, 2026 | 73.87 | 76.11 | 73.14 | 75.22 | 878.50K |
| Sep 30, 2026 | 76.55 | 76.55 | 73.76 | 74.61 | 650.60K |
| Sep 29, 2026 | 75.32 | 76.52 | 74.33 | 75.73 | 620.70K |
| Sep 28, 2026 | 75.00 | 76.42 | 74.02 | 76.10 | 734.10K |
| Sep 25, 2026 | 75.40 | 76.00 | 74.53 | 75.08 | 478.50K |
| Sep 24, 2026 | 76.02 | 76.95 | 74.46 | 75.34 | 433.30K |
| Sep 23, 2026 | 77.99 | 78.23 | 74.88 | 76.08 | 408.20K |
| Sep 22, 2026 | 78.09 | 79.54 | 77.37 | 78.00 | 403.90K |
| Sep 21, 2026 | 77.12 | 78.73 | 75.90 | 78.13 | 482.80K |
| Sep 18, 2026 | 78.95 | 79.61 | 76.99 | 77.24 | 1.06M |
About Kiniksa Pharmaceuticals International
Kiniksa Pharmaceuticals International (KNSA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LONDON. Fiscal year ends December 31. SEC CIK 1730430.
KNSA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| L.P. 667, | Director | Jun 2, 2026 |
| Bros. Advisors Lp Baker | Director | Jun 2, 2026 |
| Felix Baker | Director | Jun 2, 2026 |
| Julian Baker | Director | Jun 2, 2026 |
| Bros. Advisors (Gp) Llc Baker | Director | Jun 2, 2026 |
| Brothers Life Sciences Lp Baker | Director | Jun 2, 2026 |
| G Bradley Cole | Director | Jul 31, 2026 |
| Richard S Levy | Director | Aug 4, 2026 |
| Thomas Malley | Director | Jun 2, 2026 |
| Tracey L Mccain | Director | Jun 2, 2026 |
| Sanj K Patel | CHAIRMAN & CEO | Sep 3, 2026 |
| Kimberly J Popovits | Director | Jun 2, 2026 |
| Barry D Quart | Director | Aug 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Dhiraj H Malkani | CHIEF STRATEGY OFFICER | Jul 6, 2026 |
| Michael R Megna | CHIEF ACCOUNTING OFFICER | Sep 3, 2026 |
| Ross Moat | CHIEF OPERATING OFFICER | Sep 3, 2026 |
| John F. Paolini | CHIEF MEDICAL OFFICER | Sep 3, 2026 |
| Sanj K Patel | CHAIRMAN & CEO | Sep 3, 2026 |
| Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 3, 2026 |
| Eben Tessari | CHIEF STRATEGY OFFICER | Apr 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Michael R Megna | Sale | 4,600 | $80.30 |
| Jul 29, 2026 | G Bradley Cole | Sale | 3,673 | $81.43 |
| May 1, 2026 | John F. Paolini | Sale | 37,327 | $53.52 |
| May 1, 2026 | John F. Paolini | Sale | 21,097 | $54.04 |
| May 1, 2026 | Sanj K Patel | Sale | 48,565 | $54.02 |
| Apr 30, 2026 | Sanj K Patel | Sale | 2,141 | $54.01 |
| Apr 29, 2026 | Sanj K Patel | Sale | 22,544 | $54.01 |
| Apr 28, 2026 | Sanj K Patel | Sale | 51,750 | $54.02 |
| Apr 28, 2026 | Sanj K Patel | Sale | 243,596 | $52.02 |
| Apr 28, 2026 | Sanj K Patel | Sale | 113,673 | $51.47 |
| Apr 28, 2026 | Sanj K Patel | Sale | 74,635 | $50.43 |
| Apr 28, 2026 | Barry D Quart | Sale | 13,099 | $50.10 |
| Apr 9, 2026 | Ross Moat | Sale | 1,703 | $46.69 |
| Apr 9, 2026 | Michael R Megna | Sale | 6,625 | $46.69 |
| Apr 6, 2026 | Barry D Quart | Sale | 6,901 | $50.00 |
KNSA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $677.56M | $59.01M | 0.75 | $137.99M |
| Dec 31, 2024 | $423.24M | $-43.19M | -0.60 | $25.69M |
| Dec 31, 2023 | $270.26M | $14.08M | 0.20 | $13.30M |
| Dec 31, 2022 | $220.18M | $183.36M | 2.60 | $5.81M |
| Dec 31, 2021 | $38.54M | $-157.92M | -2.30 | $-126.30M |
Latest balance sheet: total assets $825.28M, total liabilities $219.59M, cash $189.95M (as of Mar 31, 2026).
KNSA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 28, 2026 | 8-K Item 2.02 (results) | $79.44 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $53.85 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $43.50 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $41.12 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $39.43 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $30.37 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $25.88 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $19.72 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $18.17 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $23.26 |
| Jul 23, 2024 | 8-K Item 2.02 (results) | — |
| Apr 23, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on KNSA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.